Freenome

Freenome focuses on multi-omics liquid biopsy for early cancer detection using machine learning. It emphasizes non-invasive screening tests. In contrast to Biocogniv it develops its own assays rather than analyzing third-party lab results and follows a diagnostics-as-a-service approach.